Fundraising Fox
Deffai
1 known investors
Find your way into Deffai
Sign up to see every warm intro you have to Deffai
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deffai team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Deffai is an AI-native regulatory affairs platform that helps life sciences companies prepare and strengthen FDA submissions using domain-specific AI built on review patterns and guidances. It targets biotech and medical device firms working on areas such as cell and gene therapy, vaccines, oncology, and combination products, and is staffed by former FDA reviewers and decision-makers.
Investors · 1
Related companies · 3
NansenNansen is a trading platform that combines onchain intelligence and AI to help investors discover trading opportunities, execute trades, and monitor portfolios across multiple blockchain networks and protocols. The platform enables users to analyze wallet flows, track top-performing traders, and execute trades agentic ally or manually.
DelphiDelphi is an AI-powered assistant platform that helps venture capitalists scale their investment operations by automating deal screening, founder communication, and thought leadership distribution. The platform trains on a VC's own content and investment thesis to provide personalized feedback to founders and manage deal flow 24/7.
DefinedDefined.ai provides commercially-safe visual and language content datasets for training generative AI models, ensuring creator rights protection and regulatory compliance. The company serves AI/ML developers and enterprises building AI solutions across creative, social, and ecommerce sectors.
Companies working in the same space as Deffai.
Frequently asked questions
- What does Deffai do?
- Deffai is an AI-native regulatory affairs platform that helps life sciences companies prepare and strengthen FDA submissions using domain-specific AI built on review patterns and guidances. It targets biotech and medical device firms working on areas such as cell and gene therapy, vaccines, oncology, and combination products, and is staffed by former FDA reviewers and decision-makers.
- Who are Deffai's investors?
- Deffai's investors include Sancus Ventures.